Understanding Precision Oncology
Precision oncology is a personalized approach to cancer care that uses information about a tumour’s genetic, molecular, and biological characteristics to help guide treatment decisions. Instead of relying only on the cancer’s location or type, doctors may use biomarker testing and molecular profiling to identify changes that could influence treatment options.
Biomarker-Based Treatment
Biomarker testing for cancer may involve analysing tumour tissue, blood, or other samples to look for specific genetic mutations, proteins, or molecular changes. Depending on the cancer type and test results, these findings may help doctors determine whether a patient could benefit from targeted therapy, immunotherapy, or other specialized treatments.
Who May Benefit?
Precision medicine may be considered for patients with certain cancers, particularly when standard treatment options are limited, the cancer has returned, or additional molecular information could help guide therapy. The suitability of testing depends on the cancer type, stage, previous treatments, overall health, and individual clinical circumstances.
What to Expect
The oncology team reviews medical history, pathology reports, imaging, and available biomarker results before recommending an appropriate treatment strategy. Patients should discuss the purpose of testing, possible treatment options, limitations, side effects, and expected monitoring with their treating oncologist.